Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Hosp Infect ; 105(4): 619-624, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32540461

RESUMEN

BACKGROUND: Influenza vaccination coverage is low in France, in at-risk patients and in healthcare workers. AIM: We aimed to estimate the incidence of nosocomial influenza, its characteristics and outcome. METHODS: During one influenza season, we retrospectively evaluated all cases of documented influenza. Inpatients with symptoms onset ≥48 h after admission were enrolled. Data were collected on a standardized questionnaire. RESULTS: From November 2017 to April 2018, 860 patients tested positive for influenza by polymerase chain reaction analysis on a respiratory sample. Among them, 204 (23.7%) were diagnosed ≥48 h after admission, of whom 57 (6.6% of all influenza cases) fulfilled inclusion criteria for nosocomial influenza: 26 women and 31 men, median age 82 years (interquartile range, 72.2-86.9). Twenty patients (38.6%) had recently (<6 months) received the seasonal influenza vaccine. Median time between admission and symptoms onset, and between symptoms onset and diagnosis were, respectively, 11 days (7-19.5) and 29 h (15.5-48). Influenza was mostly acquired in a double-bedded room (N = 39, 68.4%), with documented exposure in 14 cases. Influenza B virus was more common in nosocomial (46/57, 80.7%), than in community-acquired cases (359/803, 44.6%), P<0.001. Mortality rate at three months was 15.8% (N = 9). Incidence of nosocomial influenza was estimated at 0.22 per 1000 hospital-days during the study period. CONCLUSION: Nosocomial influenza is not rare in elderly inpatients, and may have severe consequences. Influenza B virus was over-represented, which suggests higher transmissibility and/or transmission clusters.


Asunto(s)
Infección Hospitalaria/epidemiología , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/epidemiología , Cobertura de Vacunación/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Infección Hospitalaria/virología , Femenino , Francia/epidemiología , Personal de Salud/estadística & datos numéricos , Hospitalización/estadística & datos numéricos , Humanos , Incidencia , Gripe Humana/prevención & control , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
2.
Ann Hematol ; 95(11): 1819-23, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27582015

RESUMEN

A high number of circulating CD34+ cells has been advocated to distinguish primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms. We re-evaluated the diagnostic interest of measuring circulating CD34+ cells in 26 healthy volunteers and 256 consecutive patients at diagnosis for whom a myeloproliferative neoplasm was suspected. The ROC curve analysis showed that a number of CD34+ <10/µl excludes the diagnosis of primary myelofibrosis with a sensitivity of 97 % and a specificity of 90 % (area under the curve: 0.93 [0.89-0.98]; p < 0.001). Patients with PMF harboring a CALR mutation had more circulating CD34+ cells than patients with either a JAK 2 or MPL mutation (p = 0.02 and p < 0.01, respectively). These results suggest that this fast, simple, non-invasive, and standardized test is of particular interest to exclude the diagnosis of primary myelofibrosis.


Asunto(s)
Recuento de Células Sanguíneas , Células Madre Hematopoyéticas , Mielofibrosis Primaria/diagnóstico , Antígenos CD34/análisis , Área Bajo la Curva , Calreticulina/genética , Análisis Mutacional de ADN , Humanos , Janus Quinasa 2/genética , Mutación , Síndromes Mielodisplásicos/sangre , Síndromes Mielodisplásicos/diagnóstico , Trastornos Mieloproliferativos/sangre , Trastornos Mieloproliferativos/diagnóstico , Mielofibrosis Primaria/sangre , Mielofibrosis Primaria/genética , Curva ROC , Receptores de Trombopoyetina/genética , Estudios Retrospectivos , Sensibilidad y Especificidad
3.
Prog Urol ; 23(10): 899-905, 2013 Sep.
Artículo en Francés | MEDLINE | ID: mdl-24034803

RESUMEN

INTRODUCTION: Urinary lithiasis in children is relatively seldom in France as in industrialized countries. The determination of their etiology based on their composition may lead to a better treatment. METHOD: One hundred and eight urinary calculi from 6 months through 18-year-old children were analyzed by using spectrophotometry, in order to specify their structure. Six groups were evidenced through a multidimensional analysis based on the presence of components weighing at least 5% of the total. RESULTS: The youngest children affected were mostly boys, and the sex ratio switched after 12.5 years. Above 14 years of age, the number of calculi significantly raised. Their composition varied with the gender, and their localization with the age. Finally a correlation between infection and composition of the calculus was shown in our study. CONCLUSION: The classification of calculi among six groups according to their composition, along with clinical informations and morphologic studies, has proven its value in determining the etiology of the lithiasis. These data help to better understand the kind of lithiasis that may be observed and the physiopathology of the mechanism explaining it from the gender and age.


Asunto(s)
Cálculos Urinarios/clasificación , Adolescente , Distribución por Edad , Oxalato de Calcio/análisis , Niño , Preescolar , Femenino , Francia , Humanos , Lactante , Pelvis Renal/anomalías , Masculino , Fosfatos/análisis , Estudios Retrospectivos , Distribución por Sexo , Espectrofotometría , Uréter/anomalías , Cálculos Urinarios/química , Cálculos Urinarios/epidemiología , Infecciones Urinarias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...